ZURICH, 27-Mar-2018 — /EuropaWire/ — UZH researchers have developed a novel method that speeds up the process of determining crystal structures of organic salts and significantly reduces the effort required to do so. As about 40 percent of all active pharmaceutical … Read the full press release
Sandoz is seeking approval of biosimilar infliximab for use in all indications of its reference medicine across gastroenterology, rheumatology and dermatology Positive opinion is based on comprehensive clinical and non-clinical data that is expected to confirm that Sandoz biosimilar infliximab … Read the full press release
Extension of the European overland pharma cross dock platform in Luxembourg for more frequent departures and faster transit times Complete coverage to all European destinations Enhanced real time monitoring solutions for temperature sensitive pharma shipments Contern, Luxembourg, 26-Mar-2018 — /EuropaWire/ … Read the full press release
Posted in Business, Luxembourg, Pharma & Biotech, Transportation & Logistics
Tagged Contern, Kuehne + Nagel, logistics, Luxembourg, pharma, pharma solutions, telematics, Uwe Hött
LONDON, 22-Mar-2018 — /EuropaWire/ — GSK today announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with systemic lupus erythematosus (SLE). Belimumab and rituximab have different but potentially complementary mechanisms of action. … Read the full press release
Posted in Healthcare, Pharma & Biotech, United Kingdom
Tagged belimumab, Gijs van den Brink, GSK, lupus, rituximab, SLE, systemic lupus erythematosus
BASEL, 20-Mar-2018 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane [albumin-bound … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged atezolizumab, Cancer, chemotherapy, lung, lung cancer, lungcancer, Roche, Sandra Horning, squamous
Lundbeck will make an upfront payment of EUR 100 million and the deal terms also include up to EUR 805 million in development, regulatory and sales milestones Foliglurax is a first-in-class treatment which entered clinical phase II testing in Parkinson’s … Read the full press release
Posted in Business, Denmark, Netherlands, Pharma & Biotech
Tagged acquisition, Anders Götzsche, dopaminergic, dyskinesia, Foliglurax, H. Lundbeck A/S, Parkinson's, Prexton Therapeutics BV, PTX002331
World Pharma Pricing and Market Access Congress 2018 Business Design Centre, London United Kingdom SOMERSET, N.J. / LONDON, UK, 19-Mar-2018 — /EuropaWire/ — Alliance Life Sciences, a leading global life sciences consulting, pricing data and technology provider, announced that it is … Read the full press release
Posted in France, Germany, Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged advanced therapies, AI, Alan Crowther, Alliance Life Sciences, Big Data, Biotech, Commercial Operations, Contracting, diagnostic firms, Global Pricing, life sciences companies, life sciences consulting, management software, Market Access, medical device, medical device firms, pharma, pharma pricing, Pharmaceutical, pharmaceutical manufacturers, ppma, ppmaconf, PricentricOne, PriceRight, rare diseases, Reimbursement, Sophie Ferronato, tender, Water Street Healthcare Partners, Water Street partners, World Pharma Pricing and Market Access Congress
‘Smart’ CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management DUBLIN, 13-Mar-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received … Read the full press release
Posted in Healthcare, Ireland, Pharma & Biotech
Tagged Annette Brüls, Diabetes, Dr. Timothy Bailey, glucose, Medtronic, predictive, US FDA
Medtronic Seeks Up to 20 Runners Who Benefit from Medical Technology Selected Runners Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October 2018 Applications Accepted at www.medtronic.com/globalchampions DUBLIN, 13-Mar-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), … Read the full press release
Posted in Healthcare, Ireland, Pharma & Biotech, Science, Technology
Tagged 2018 Medtronic Global Champions, healthtech, medtech, Medtronic plc, Rob Clark, startup
Clinical and real-world insights on recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and the management of chronic hypoparathyroidism to be presented Hypoparathyroidism is a rare endocrine disease that can have a significant impact on patients New data highlight Shire’s commitment to … Read the full press release
A rare mineral with potential industrial and medical applications has been discovered on alpine plants at Cambridge University Botanic Garden. CAMBRIDGE, 07-Mar-2018 — /EuropaWire/ — Scientists at Sainsbury Laboratory Cambridge University have found that the mineral vaterite, a form (polymorph) … Read the full press release
CAMBRIDGE, 07-Mar-2018 — /EuropaWire/ — Researchers from the UK and Denmark have developed a new method to predict the physical stability of drug candidates, which could help with the development of new and more effective medicines for patients. The technology has … Read the full press release
Posted in Denmark, Education, Healthcare, Pharma & Biotech, United Kingdom
Tagged DRUGS, medicines, pharma, Professor Axel Zeitler, solids, University of Cambridge, University of Copenhagen
Medicine to be voluntarily withdrawn from the market by the company LONDON, 06-Mar-2018 — /EuropaWire/ — The European Medicines Agency (EMA) has started an urgent review of the multiple sclerosis medicine Zinbryta (daclizumab) following 7 cases of serious inflammatory brain disorders … Read the full press release
Novartis and Pear Therapeutics to collaborate on prescription software applications aimed to treat patients with schizophrenia and multiple sclerosis Collaboration combines Novartis’ leadership in biomedical research and clinical development with Pear’s expertise in digital therapeutics Novartis continues to embrace emerging … Read the full press release
BASEL, 05-Mar-2018 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Adesh Kaul will join Basilea’s Management Committee as Chief Corporate Development Officer effective March 01, 2018. He will continue to be responsible for strategic planning, business development & … Read the full press release
Posted in Pharma & Biotech, Switzerland
Tagged Adesh Kaul, Basilea Pharmaceutica, leadership, Management, pharma, Ronald Scott
AMSTERDAM, 28-Feb-2018 — /EuropaWire/ — AkzoNobel Specialty Chemicals is extending its offering of Kromasil silica products to support a key separation process used in drug development. The new Kromasil line targets supercritical fluid chromatography (SFC), which has emerged as a … Read the full press release
First Health Canada approved treatment for rare and aggressive type of skin cancer MISSISSAUGA, ON, 26-Feb-2018 — /EuropaWire/ — Merck, which operates as EMD Serono in the US and Canada, and Pfizer Canada Inc. announced that Health Canada has approved BAVENCIO™ … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech
Tagged BAVENCIO™, cancer #skin cancer, Dr. John Walker, EMD Serono, health, Health Canada, Kathy Barnard, Merck, Merkelcell carcinoma, Pfizer Canada, skin, tumour
PARIS, 26-Feb-2018 — /EuropaWire/ — Sanofi announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), applicable to Sanofi’s proposed acquisition of Bioverativ Inc. (“Bioverativ”, NASDAQ: BIVV) has expired. On February 7, … Read the full press release
Posted in Business, France, Pharma & Biotech
Tagged acquisition, ANTITRUST, Bioverativ, Hart-Scott-Rodino Antitrust Improvements Act, Healthcare, HSRAct, Sanofi
Imfinzi is the only immunotherapy approved for patients with unresectable Stage III non-small cell lung cancer Imfinzi showed an 11.2 month improvement in median progression-free survival (16.8 months compared to 5.6 months on placebo) CAMBRIDGE, 22-Feb-2018 — /EuropaWire/ — AstraZeneca and … Read the full press release
Posted in Healthcare, Pharma & Biotech, United Kingdom
Tagged AstraZeneca, Cancer, chemotherapy, Dave Fredrickson, Imfinzi, lung, lung cancer, lungcancer, MedImmune, radiation therapy, Scott J. Antonia MD Ph.D.
STUTTGART, 15-Feb-2018 — /EuropaWire/ — McKesson Europe has published its first Europe-wide Corporate Responsibility Report in accordance with the international Global Reporting Initiative (GRI) guidelines: The company provides insights into its sustainable handling of economic and ecological resources and informs readers … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?